Efficacy and safety of oral tofacitinib for induction therapy in patients with moderate-to-severe Crohn's disease: results of a Phase 2b randomised placebo-controlled trial.

Tools

Panes, J., Sandborn, W. J., Schreiber, Stefan, Sands, B. E., Vermeire, S., Chan, G., Moscariello, M., Wang, W., Niezychowski, W., Marren, A., Healey, P. and Maller, E. (2016) Efficacy and safety of oral tofacitinib for induction therapy in patients with moderate-to-severe Crohn's disease: results of a Phase 2b randomised placebo-controlled trial. Journal of Crohns & Colitis, 10 . S18-S19. DOI 10.1016/S0016-5085(16)30698-9.

Full text not available from this repository.

Supplementary data:

Document Type: Article
Additional Information: Times Cited: 0 Panes, J. Sandborn, W. J. Schreiber, S. Sands, B. E. Vermeire, S. Chan, G. Moscariello, M. Wang, W. Niezychowski, W. Marren, A. Healey, P. Maller, E. 1
Research affiliation: Kiel University
Kiel University > Kiel Marine Science
OceanRep > The Future Ocean - Cluster of Excellence
Refereed: Yes
Open Access Journal?: No
Publisher: Elsevier
Projects: Future Ocean
Date Deposited: 27 Feb 2017 08:52
Last Modified: 23 Sep 2019 19:37
URI: https://oceanrep.geomar.de/id/eprint/36239

Actions (login required)

View Item View Item